Saturday, May 25, 2013

Serving patients is a privilege that comes with responsibilities...

Our Mission:

 Protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain


Rx-360 Releases Two New Supply Chain Security White Papers

 

Rx-360 White Paper on Illegal Diversion of Pharmaceuticals: contextualize the causes and impact of illegal diversion with case studies specific to this issue. Successful mitigation strategies for illegal diversion within the global pharmaceutical supply chain will be highlighted.  To read the White paper go to: 
http://hosted-p0.vresp.com/427409/9a6cffc96f/ARCHIVE

 

Rx-360 White Paper on Mitigating Risk to the Supply Chain - Drug Shortage Working Group reviews some potential mitigation steps for companies to consider if they have a drug shortage to prevent criminals from exploiting the shortage. To read the White paper go to: 
http://hosted-p0.vresp.com/427409/28d02cb4c8/ARCHIVE

 

 

Rx-360 Congratulates FDA and Deb Autor for Developing and Sharing Counterfeit Detectors to Aid Battle Against Malaria 

Deborah M. Autor
 

Somewhere right now, malaria patients facing a life-threatening illness are being treated with counterfeit or substandard anti-malarial drugs, including falsified products, that threaten their recovery and can contribute to drug resistance. We are proud to announce the Food and Drug Administration’s launch of a partnership that will use a clever, innovative tool invented by FDA scientists to quickly and cheaply test suspect counterfeit or substandard anti-malarial drugs, including falsified products. The partnership will test the effectiveness of this hand-held, battery-operated tool, called Counterfeit Detection Device, Version 3, or, simply, CD-3. It will be deployed first in Ghana and then, after data is collected, in a second testing region. Read More

 

Rx-360 Endorses GS1 Healthcare Standards Along with 30 Other Industry Leaders

Today, Rx-360 is proud to support GS1 Healthcare Standards along with 30 global healthcare leaders.  Brian Johnson, Rx-360 Chair stated "In today’s complex global marketplace the need for global standards has never been greater.  Rx360 strongly endorses the work GS1 has been doing in the healthcare arena.  Our patients will ultimately be the winners through enhanced supply chain integrity which relies on the utilization of global standards."
 

British Fake Pharmacy Actually Selling Counterfeit Drugs From Pakistan: Four Sentenced

4 Wales residents were sentenced in a counterfeit drugs case spanning Europe. The four accepted delivery of counterfeit & illicit drugs from Pakistan, which they then repackaged and shipped to online customers in the European Union.  To read full article go to SafeMedicines.org
 
   

Rx-360 Rleases New Smart Phone APP for Android Phones, IPads and IPhones

Today, Rx-360 is proud to announce the launch of IPad and IPhone Apps that provide everything that you may need to know about the pharmaceutical supply chain and the quality of material within the supply chain.

 

                                                                                                          

 

 

woodcok               

 A Thought Provoking Article Aimed at Reducing Shortages
"Economic and technological drivers of generic sterile injectable drug shortages"

Over the past few years, an increasing number of critically needed medicines have been in short supply. Using economic theory to frame the drug-shortage problem, this paper explores why and how manufacturing-quality problems could combine with other economic and technological factors to result in shortages of generic sterile injectable drugs. 

To read the entire article, click here

 


 

 

Come See Rx-360 at PDA - FDA Supply Chain Workshop on June 3-5, 2013 Minimize

Come to the workshop to learn about supply chain security during interesting and entertaining presentations such as the recent presentation on Counterfeiting at the PDA Annual Meeting, whcih can be watched below:

  


 Join Our Members and Your Colleagues Protecting Patients

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

  

 

Eli Lilly

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

Enough talk,

it is now time for decisive action.

Join Rx-360 Today! 

<<
[1/85]Members
[2/85]Rx-360
[3/85]Abbvie
[4/85]Alcon
[5/85]Amgen
[6/85]AMPAC
[7/85]Amylin
[8/85]APIC
[10/85]AstraZeneca
[11/85]Aurisco
[12/85]Avantor
[13/85]BASF
[14/85]Baxter
[15/85]Bayer
[16/85]Bergamo
[17/85]Biogen
[19/85]BI
[20/85]BMS
[22/85]Cardinal
[23/85]Centocor
[24/85]Cephalon
[25/85]CRN
[27/85]Doe Ingalls
[28/85]DSM
[29/85]EFCG
[30/85]EGA
[32/85]Eli Lilly
[33/85]Forest Labs
[35/85]GSK
[36/85]GE
[37/85]Genentech
[38/85]Hikal
[39/85]Hospira
[40/85]Hovione
[41/85]IPEC
[42/85]JnJ
[43/85]Janssen
[44/85]LaboChim
[46/85]LifeConEx
[47/85]Ligand
[48/85]McNeil
[49/85]MSD
[50/85]Merck
[52/85]Members
[53/85]MultiPharma
[54/85]MN
[55/85]Mylan
[56/85]Myoderm
[57/85]Novartis
[58/85]Novozymes
[59/85]OSO
[60/85]NSD
[61/85]PDA
[62/85]Perrigo
[63/85]Pfizer
[64/85]PhRMA
[65/85]PSC
[66/85]PQG
[67/85]RCA
[68/85]Rephine
[69/85]RMC
[70/85]Roche
[71/85]Sandoz
[72/85]Safis
[73/85]Sartorius
[74/85]Schering
[76/85]Spectrum
[77/85]SQA Services
[78/85]STS
[79/85]Takeda
[80/85]ucb
[81/85]VWR
[82/85]Watson
[85/85]Membership

 

 

To View or Download the Presentation 
Click on the Slide Above

To see other presentations, click here

 

 

 


Additional Resources to Help Fight for Patient Safety

 

The Partnership for Safe Medicines

 

 Home

 

<<
[1/7]IPQ
[3/7]IPEC
[4/7]APIC
[5/7]PCSC
[7/7]PSI
Events Minimize
Event StartEvent EndTitle

    

ABC News Report on Counterfeits Minimize
ABC News
  

60 Minutes Investigates Counterfeit Drugs Minimize
60 Minutes Report
  

Counterfeit Avastin Video Minimize
Counterfeit Avastin
  


Daily News
(To Read More, Click on the Title of the Article Below)

 


 

2009 © Rx-360